Overview

Evaluation of Topical and Intravenous Tranexamic Acid in Surgical Treatment of Lumbar Degenerative Disease

Status:
Enrolling by invitation

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

Lumbar degenerative disease surgery entails in a high blood loss, requiring often for blood transfusion. The cost and risks involved in the use of allogeneic blood have motivated research methods to reduce operative bleeding in these patients. One such method is the use of anti-fibrinolytic drugs, among which is tranexamic acid.

Phase:

Phase 3

Details

Lead Sponsor:

Instituto Nacional de Traumatologia e Ortopedia

Treatments:

Pharmaceutical Solutions
Tranexamic Acid